Zhenkun Ma

4.8k total citations
96 papers, 3.4k citations indexed

About

Zhenkun Ma is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Zhenkun Ma has authored 96 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 30 papers in Infectious Diseases and 29 papers in Organic Chemistry. Recurrent topics in Zhenkun Ma's work include Tuberculosis Research and Epidemiology (21 papers), Cancer therapeutics and mechanisms (20 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (12 papers). Zhenkun Ma is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Cancer therapeutics and mechanisms (20 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (12 papers). Zhenkun Ma collaborates with scholars based in United States, China and New Zealand. Zhenkun Ma's co-authors include James M. Bobbitt, Scott G. Franzblau, Khisimuzi Mdluli, William A. Denny, Andrew M. Thompson, Christian Lienhardt, Adrian Blaser, Andrew Nunn, Helen McIlleron and Brian D. Palmer and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Zhenkun Ma

92 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenkun Ma United States	35	1.6k	1.3k	1.0k	834	327	96	3.4k
Benoît Déprez France	33	2.1k 1.3×	1.2k 1.0×	496 0.5×	549 0.7×	296 0.9×	134	4.1k
Maria Paola Costi Italy	31	1.7k 1.1×	850 0.7×	341 0.3×	602 0.7×	335 1.0×	171	3.3k
Sudhir Sinha India	35	1.1k 0.7×	1.9k 1.5×	830 0.8×	652 0.8×	263 0.8×	123	3.6k
Luiz Augusto Basso Brazil	37	2.7k 1.7×	667 0.5×	1.5k 1.5×	942 1.1×	275 0.8×	221	4.2k
James R. Fuchs United States	45	2.7k 1.7×	1.3k 1.0×	1.0k 1.0×	278 0.3×	416 1.3×	112	5.6k
Mariangela Biava Italy	32	928 0.6×	1.3k 1.0×	738 0.7×	478 0.6×	371 1.1×	102	2.6k
Yongcheng Song United States	42	2.9k 1.9×	1.0k 0.8×	560 0.5×	264 0.3×	330 1.0×	106	4.9k
Yongbing Cao China	33	1.2k 0.7×	785 0.6×	1.2k 1.2×	767 0.9×	327 1.0×	135	3.5k
Mario Sechi Italy	41	1.5k 1.0×	948 0.7×	420 0.4×	335 0.4×	287 0.9×	96	4.0k
Mahmoud E. S. Soliman South Africa	33	2.2k 1.4×	1.5k 1.1×	829 0.8×	332 0.4×	362 1.1×	299	5.1k

Countries citing papers authored by Zhenkun Ma

Since Specialization

Citations

This map shows the geographic impact of Zhenkun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenkun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenkun Ma more than expected).

Fields of papers citing papers by Zhenkun Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenkun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenkun Ma. The network helps show where Zhenkun Ma may publish in the future.

Co-authorship network of co-authors of Zhenkun Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenkun Ma. A scholar is included among the top collaborators of Zhenkun Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenkun Ma. Zhenkun Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al‐Ibrahim, Mohamed, B. Keck, Stephen English, et al.. (2025). P-1117. An Open-label Phase 1 Study in Healthy Adult Male Participants to Investigate the Absorption, Metabolism, and Excretion of [14C]-Rifaquizinone Following a Single Intravenous Administration. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Overcash, J. Scott, et al.. (2025). P-1090. Rifaquizinone for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Multicenter, Double-Blind, Randomized, Active-Controlled, Phase 2 Trial. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Ma, Zhenkun, et al.. (2025). Effect of hypertension on clinical outcomes in ischemic colitis. Annals of Medicine. 57(1). 2544890–2544890.

Wang, Xiaojuan, He Wang, Zhenkun Ma, et al.. (2025). Visible‐Light‐Induced C−H Amidation of (Hetero)arenes with Hypervalent Iodine(III) Reagents. Asian Journal of Organic Chemistry. 14(5).

Li, Xiaojiao, Meng Wang, Lei Gao, et al.. (2024). Safety, pharmacokinetics, and efficacy of rifasutenizol, a novel dual-targeted antibacterial agent in healthy participants and patients in China with Helicobacter pylori infection: four randomised clinical trials. The Lancet Infectious Diseases. 24(6). 650–664. 6 indexed citations

Zhao, Yang, Jiaqi Chen, Tianjie Liu, et al.. (2023). Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS/miR-214-3p/CCL5 pathway. Asian Journal of Andrology. 26(2). 195–204. 7 indexed citations

Ma, Zhenkun, Ying Yuan, Yu Liu, et al.. (2022). Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens. Journal of Medicinal Chemistry. 65(6). 4481–4495. 18 indexed citations

Thompson, Andrew M., P. D. T. O’Connor, Vanessa Yardley, et al.. (2021). Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced Solubility. ACS Medicinal Chemistry Letters. 12(2). 275–281. 10 indexed citations

Ding, Jun, Qian Zhang, Xiaomei Wang, et al.. (2020). Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria. Molecules. 25(10). 2431–2431. 9 indexed citations

10.

Yuan, Ying, Xiaomei Wang, Yu Liu, et al.. (2019). Evaluation of a Dual-Acting Antibacterial Agent, TNP-2092, on Gut Microbiota and Potential Application in the Treatment of Gastrointestinal and Liver Disorders. ACS Infectious Diseases. 6(5). 820–831. 17 indexed citations

11.

Zhao, Yang, Jiaqi Chen, Hongjun Xie, et al.. (2019). Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation. Cancer Letters. 473. 118–129. 27 indexed citations

12.

Guan, Bing, Kaijie Wu, Jin Zeng, et al.. (2016). Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer. Oncotarget. 8(5). 8162–8172. 55 indexed citations

13.

Zhou, Jiancheng, Kaijie Wu, Guodong Zhu, et al.. (2014). Reciprocal Regulation of Hypoxia-Inducible Factor 2α and GLI1 Expression Associated With the Radioresistance of Renal Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 90(4). 942–951. 34 indexed citations

14.

Guan, Zhenfeng, Jin Zeng, Hongjun Xie, et al.. (2013). Urine tenascin-C is an independent risk factor for bladder cancer patients. Molecular Medicine Reports. 9(3). 961–966. 10 indexed citations

15.

Maroz, Andrej, S.S. Shinde, Scott G. Franzblau, et al.. (2009). Release of nitrite from the antitubercular nitroimidazoledrug PA-824 and analogues upon one-electron reduction in protic, non-aqueous solvent. Organic & Biomolecular Chemistry. 8(2). 413–418. 11 indexed citations

16.

Mdluli, Khisimuzi & Zhenkun Ma. (2007). Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery. Infectious Disorders - Drug Targets. 7(2). 159–168. 124 indexed citations

17.

Kim, In Ho, Keith D. Combrink, Zhenkun Ma, et al.. (2006). Synthesis and antibacterial evaluation of a novel series of rifabutin-like spirorifamycins. Bioorganic & Medicinal Chemistry Letters. 17(5). 1181–1184. 12 indexed citations

18.

Combrink, Keith D., Zhenkun Ma, Dalai Yan, et al.. (2006). New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases. Bioorganic & Medicinal Chemistry Letters. 17(2). 522–526. 30 indexed citations

19.

Gu, Yu, Richard F. Clark, Zhenkun Ma, et al.. (2005). Design, synthesis and structure–activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae. Bioorganic & Medicinal Chemistry Letters. 15(10). 2653–2658. 12 indexed citations

20.

Akritopoulou‐Zanze, Irini, Zhenkun Ma, Greg Stone, et al.. (2004). Synthesis and antibacterial activity of novel bifunctional macrolides. Bioorganic & Medicinal Chemistry Letters. 14(14). 3809–3813. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact